Lu to human B-cell lymphoma xenografts in mice.Lu-labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-biotin second step reagent.Lu-PRIT. Toxicities were comparable with both isotopes.Lu for streptavidin-biotin PRIT approaches in these human lymphoma xenograft models
In a pretargeting radioimmunotherapy system, monoclonal antibodies (MAbs) derivatised with a high af...
Wedeterminedwhether therapeutic responses using a bispecific antibody that pretargeted 90Y-hapten-pe...
Wedeterminedwhether therapeutic responses using a bispecific antibody that pretargeted 90Y-hapten-pe...
Radiolabeled anti-CD20 antibodies pro-duce responses in 60 % to 95 % of patients with relapsed non-H...
Pretargeted radioimmunotherapy (RIT) using streptavidin (sAv)-conjugated antibodies before radiolabe...
<div><p>Purpose</p><p>Pretargeted radioimmunotherapy (PRIT) is a multi-step method of selectively de...
grantor: University of TorontoIn this study pre-targeted radioimmunotherapy (RIT) of athym...
grantor: University of TorontoIn this study pre-targeted radioimmunotherapy (RIT) of athym...
Streptavidin (SA)-biotin pretargeted radioimmunotherapy (PRIT) that targets CD20 in non-Hodgkin lymp...
Previous studies have shown that pretargeting protocols, using cancer-targeting fusion proteins, com...
Pretargeted radioimmunotherapy (PRIT) using streptavidin (SAv)-biotin technology can deliver higher ...
Pretargeted radioimmunotherapy (PRIT) using streptavidin (SAv)-biotin technology can deliver higher ...
© 2020 American Association for Cancer Research. Pretargeted radioimmunotherapy (PRIT) has been inve...
Pretargeted radioimmunotherapy (PRIT) has been investigated as a multi-step approach to decrease rel...
Pretargeting involves administration of a tumor-targeting mono-clonal antibody (mAb) covalently link...
In a pretargeting radioimmunotherapy system, monoclonal antibodies (MAbs) derivatised with a high af...
Wedeterminedwhether therapeutic responses using a bispecific antibody that pretargeted 90Y-hapten-pe...
Wedeterminedwhether therapeutic responses using a bispecific antibody that pretargeted 90Y-hapten-pe...
Radiolabeled anti-CD20 antibodies pro-duce responses in 60 % to 95 % of patients with relapsed non-H...
Pretargeted radioimmunotherapy (RIT) using streptavidin (sAv)-conjugated antibodies before radiolabe...
<div><p>Purpose</p><p>Pretargeted radioimmunotherapy (PRIT) is a multi-step method of selectively de...
grantor: University of TorontoIn this study pre-targeted radioimmunotherapy (RIT) of athym...
grantor: University of TorontoIn this study pre-targeted radioimmunotherapy (RIT) of athym...
Streptavidin (SA)-biotin pretargeted radioimmunotherapy (PRIT) that targets CD20 in non-Hodgkin lymp...
Previous studies have shown that pretargeting protocols, using cancer-targeting fusion proteins, com...
Pretargeted radioimmunotherapy (PRIT) using streptavidin (SAv)-biotin technology can deliver higher ...
Pretargeted radioimmunotherapy (PRIT) using streptavidin (SAv)-biotin technology can deliver higher ...
© 2020 American Association for Cancer Research. Pretargeted radioimmunotherapy (PRIT) has been inve...
Pretargeted radioimmunotherapy (PRIT) has been investigated as a multi-step approach to decrease rel...
Pretargeting involves administration of a tumor-targeting mono-clonal antibody (mAb) covalently link...
In a pretargeting radioimmunotherapy system, monoclonal antibodies (MAbs) derivatised with a high af...
Wedeterminedwhether therapeutic responses using a bispecific antibody that pretargeted 90Y-hapten-pe...
Wedeterminedwhether therapeutic responses using a bispecific antibody that pretargeted 90Y-hapten-pe...